Generics BulletinUK liquids specialist Rosemont Pharmaceuticals has switched CEO, at the same time as the firm announced that it had appointed Sharon Curran to become chairperson as part of its continuing push towards
Generics BulletinArrotex, the merger of Arrow Pharmaceuticals and Apotex Australia, is looking to position itself as one of Australia’s leading biosimilars suppliers after striking a strategic agreement with Celltrion
Generics BulletinCelltrion has outlined a multi-phase strategy to mitigate risks from evolving US pharmaceutical tariffs, anchored by its selection as the preferred bidder for the acquisition of a large-scale cGMP bio
Generics BulletinCelltrion has become the third firm to launch denosumab biosimilars in the US, announcing that its Stoboclo and Osenvelt (denosumab-bmwo) rivals to Amgen’s Prolia and Xgeva are now commercially availa